scispace - formally typeset
L

Luigi D. Notarangelo

Researcher at National Institutes of Health

Publications -  121
Citations -  9456

Luigi D. Notarangelo is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Severe combined immunodeficiency & Immunodeficiency. The author has an hindex of 51, co-authored 121 publications receiving 8872 citations. Previous affiliations of Luigi D. Notarangelo include University of Brescia.

Papers
More filters
Journal ArticleDOI

X-Linked Lymphoproliferative Disease 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected Cells

TL;DR: It is shown that, in patients with X-linked lymphoproliferative disease (XLP), a severe inherited immunodeficiency characterized by critical mutations in the SH2D1A gene and by the inability to control Epstein-Barr virus infections, 2B4 not only fails to transduce triggering signals, but also mediates a sharp inhibition of the NK-mediated cytolysis.
Journal ArticleDOI

Gntb-A, a Novel Sh2d1a-Associated Surface Molecule Contributing to the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected B Cells in X-Linked Lymphoproliferative Disease

TL;DR: Analysis of NK cells derived from patients with X-linked lymphoproliferative disease (XLP) showed that the lack of SH2D1A protein profoundly affects the function not only of 2B4 but also of NTB-A, which appears to play an important role in the inability of XLP-NK cells to kill EBV-infected target cells.